ARTICLE | Management Tracks
Sanofi’s Zehnder to lead CureVac
Plus: new CEOs at Novavax, Intergalactic, Evoq and Helsinn, and updates from ADARx, Acadia and more
January 9, 2023 11:23 PM UTC
After serving more than a decade on the management team and three years as CEO of CureVac N.V. (NASDAQ:CVAC), Franz Haas will step down on March 31. Alexander Zehnder will succeed him as the new CEO from April 1. Zehnder will join from Sanofi (Euronext:SAN; NASDAQ:SNY), where he is global head of oncology.
Novavax Inc. (NASDAQ:NVAX) named John Jacobs as president and CEO, effective Jan. 23, succeeding Stanley Erck, who will serve as an adviser to the company for the next 15 months. Jacobs was president, CEO and a board member at Harmony Biosciences Holdings Inc. (NASDAQ:HRMY)...